FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
2,545 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Vyalevfoscarbidopa/foslevodopa | Foscarbidopa 12 mg/mL; Foslevodopa 240 mg/mL | InjectionSubcutaneous | AbbVie Inc. | NDA | 0074-0501 | 00074-0501-01 | — |
| Vybriquesildenafil citrate | Sildenafil citrate 25 mg/1 | FilmOral | IBSA Pharma Inc. | NDA | 71858-0205 | 71858-0205-0271858-0205-0471858-0205-05+1 more | — |
| Vybriquesildenafil citrate | Sildenafil citrate 50 mg/1 | FilmOral | IBSA Pharma Inc. | NDA | 71858-0210 | 71858-0210-0171858-0210-0271858-0210-04+2 more | — |
| Sildenafil citrate 75 mg/1 |
| FilmOral |
| IBSA Pharma Inc. |
| NDA |
| 71858-0215 |
| 71858-0215-0171858-0215-0271858-0215-04+2 more |
| — |
| Vybriquesildenafil citrate | Sildenafil citrate 100 mg/1 | FilmOral | IBSA Pharma Inc. | NDA | 71858-0220 | 71858-0220-0171858-0220-0271858-0220-04+2 more | — |
|---|
| Vyeptieptinezumab-jjmr | Eptinezumab 100 mg/mL | InjectionIntravenous | Lundbeck Pharmaceuticals LLC | BLA | 67386-130 | 67386-0130-5167386-0130-91 | — |
|---|
| Vyfemlanorethindrone and ethinyl estradiol | — | Kit | Lupin Pharmaceuticals, Inc. | ANDA | 68180-875 | 68180-0875-73 | — |
|---|
| Vyjuvek | — | Kit | Krystal Biotech, Inc. | BLA | 82194-510 | 82194-0510-02 | — |
|---|
| Vykat XRdiazoxide choline | Diazoxide choline 25 mg/1 | Tablet, Film coatedOral | Soleno Therapeutics, Inc. | NDA | 83860-025 | 83860-0025-01 | — |
|---|
| Vykat XRdiazoxide choline | Diazoxide choline 75 mg/1 | Tablet, Film coatedOral | Soleno Therapeutics, Inc. | NDA | 83860-075 | 83860-0075-01 | — |
|---|
| Vykat XRdiazoxide choline | Diazoxide choline 150 mg/1 | Tablet, Film coatedOral | Soleno Therapeutics, Inc. | NDA | 83860-150 | 83860-0150-01 | — |
|---|
| Vykouraleucovorin calcium | Leucovorin calcium 50 mg/5mL | InjectionIntramuscular, Intravenous | Avyxa Pharma, LLC | NDA | 83831-147 | 83831-0147-05 | — |
|---|
| Vykouraleucovorin calcium | Leucovorin calcium 350 mg/35mL | InjectionIntramuscular, Intravenous | Avyxa Pharma, LLC | NDA | 83831-148 | 83831-0148-35 | — |
|---|
| Vykouraleucovorin calcium | Leucovorin calcium 500 mg/50mL | InjectionIntramuscular, Intravenous | Avyxa Pharma, LLC | NDA | 83831-149 | 83831-0149-50 | — |
|---|
| Vyleesibremelanotide | Bremelanotide acetate 1.75 mg/.3mL | InjectionSubcutaneous | Cosette Pharmaceuticals, Inc. | NDA | 0713-0897 | 00713-0897-04 | — |
|---|
| VyLibranorgestimate and ethinyl estradiol | — | Kit | Afaxys Pharma, LLC | ANDA | 50102-235 | 50102-0235-1150102-0235-13 | — |
|---|
| Vyloyzolbetuximab | Zolbetuximab 20 mg/mL | Injection, Powder, For suspensionIntravenous | Astellas Pharma US, Inc. | BLA | 0469-3425 | 00469-3425-10 | — |
|---|
| Vyloyzolbetuximab | Zolbetuximab 20 mg/mL | Injection, Powder, For suspensionIntravenous | Astellas Pharma US, Inc. | BLA | 0469-4425 | 00469-4425-30 | — |
|---|
| Vyndamaxtafamidis | Tafamidis 61 mg/1 | Capsule, Liquid filledOral | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-8730 | 00069-8730-30 | — |
|---|
| Vyndaqeltafamidis meglumine | Tafamidis meglumine 20 mg/1 | Capsule, Liquid filledOral | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-1975 | 00069-1975-40 | — |
|---|
| Vyondys 53golodirsen | Golodirsen 50 mg/mL | InjectionIntravenous | Sarepta Therapeutics, Inc. | NDA | 60923-465 | 60923-0465-02 | — |
|---|
| Vyscoxacelecoxib | Celecoxib 10 mg/mL | SuspensionOral | Carwin Pharmaceutical Associates, LLC | NDA | 15370-501 | 15370-0501-16 | — |
|---|
| Vytonehydrocortisone acetate, iodoquinol | Hydrocortisone acetate 19 mg/g; Iodoquinol 10 mg/g | CreamTopical | Eckson Labs LLC | Unapproved drug (other) | 44118-704 | 44118-0704-30 | — |
|---|
| Vytorinezetimibe and simvastatin | Ezetimibe 10 mg/1; Simvastatin 10 mg/1 | TabletOral | Organon LLC | NDA | 78206-174 | 78206-0174-0178206-0174-02 | — |
|---|
| Vytorinezetimibe and simvastatin | Ezetimibe 10 mg/1; Simvastatin 20 mg/1 | TabletOral | Organon LLC | NDA | 78206-175 | 78206-0175-0178206-0175-02 | — |
|---|
| Vytorinezetimibe and simvastatin | Ezetimibe 10 mg/1; Simvastatin 40 mg/1 | TabletOral | Organon LLC | NDA | 78206-176 | 78206-0176-0178206-0176-02 | — |
|---|
| Vytorinezetimibe and simvastatin | Ezetimibe 10 mg/1; Simvastatin 80 mg/1 | TabletOral | Organon LLC | NDA | 78206-177 | 78206-0177-0178206-0177-02 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 10 mg/1 | CapsuleOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-101 | 59417-0101-10 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 20 mg/1 | CapsuleOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-102 | 59417-0102-10 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 30 mg/1 | CapsuleOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-103 | 59417-0103-10 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 40 mg/1 | CapsuleOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-104 | 59417-0104-10 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 50 mg/1 | CapsuleOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-105 | 59417-0105-10 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 60 mg/1 | CapsuleOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-106 | 59417-0106-10 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 70 mg/1 | CapsuleOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-107 | 59417-0107-10 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 10 mg/1 | Tablet, ChewableOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-115 | 59417-0115-01 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 20 mg/1 | Tablet, ChewableOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-116 | 59417-0116-01 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 30 mg/1 | Tablet, ChewableOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-117 | 59417-0117-01 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 40 mg/1 | Tablet, ChewableOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-118 | 59417-0118-01 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 50 mg/1 | Tablet, ChewableOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-119 | 59417-0119-01 | — |
|---|
| Vyvanselisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 60 mg/1 | Tablet, ChewableOral | Takeda Pharmaceuticals America, Inc. | NDA | 59417-120 | 59417-0120-01 | — |
|---|
| Vyvgartefgartigimod alfa | Efgartigimod alfa 20 mg/mL | InjectionIntravenous | argenx US | BLA | 73475-3041 | 73475-3041-05 | — |
|---|
| VYVGART Hytruloefgartigimod alfa and hyaluronidase (human recombinant) | Efgartigimod alfa 200 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL | Injection, SolutionSubcutaneous | argenx US | BLA | 73475-1221 | 73475-1221-0173475-1221-04 | — |
|---|
| VYVGART Hytruloefgartigimod alfa and hyaluronidase (human recombinant) | Efgartigimod alfa 180 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL | Injection, SolutionSubcutaneous | argenx US | BLA | 73475-3102 | 73475-3102-03 | — |
|---|
| Vyxeos(daunorubicin and cytarabine) liposome | Cytarabine 100 mg/20mL; Daunorubicin 44 mg/20mL | Injection, Powder, Lyophilized, For suspensionIntravenous | Jazz Pharmaceuticals, Inc. | NDA | 68727-745 | 68727-0745-0168727-0745-02 | — |
|---|
| Vyzultalatanoprostene bunod | Latanoprostene bunod .24 mg/mL | Solution/ dropsOphthalmic | Bausch & Lomb Incorporated | NDA | 24208-504 | 24208-0504-0124208-0504-0224208-0504-05+1 more | — |
|---|